DENTSPLY SIRONA

XRAY

Medical - Instruments & Supplies · Healthcare

Also trades as: 0I8F.L

Price

$11.41

-0.20 (-1.72%)

pre-market:$11.29-1.05%

Market Cap

$2.29B

Exchange

NASDAQ

Winston Score

Winston is worried

Below-average fundamentals — multiple weak pillars.

Data as of Aug 13, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Mixed

Growth

Weak

Cash Flow

Weak

Stability

Good

Valuation

Data not available

Dividends

Good

Track this stock — start free trial

Share count falling — buybacks

−9.4% over 4y

The company has reduced its share count over this period, returning value to shareholders through buybacks.

Diluted shares outstanding: 220.2M (2021) → 199.4M (2025)

Winston Score History

The full picture

Dentsply Sirona makes tools and supplies that dentists use every day. Its products include dental implants, braces, crowns, X-ray machines, and the materials dentists use to fill cavities or clean teeth. The company sells to dental offices, clinics, and dental schools around the world, making it one of the largest dental products companies globally.

The company earns money by selling both equipment (like imaging machines and dental chairs) and consumable supplies that dentists reorder regularly, such as materials and small instruments. Dentsply Sirona operates in over 40 countries, with significant revenue coming from North America and Europe. Its broad product portfolio and long-standing relationships with dental professionals give it some competitive staying power, but the company has faced pressure from slowing dental procedure volumes, internal restructuring challenges, and rising competition from lower-cost rivals. A key risk going forward is whether management can successfully execute its ongoing turnaround plan and restore consistent profit growth.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-4.1% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+178.3% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$150M/ year

↓ Declining (-9% vs prior year)

4.1% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

0.6%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$239M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

DENTSPLY SIRONA's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

54.9%

Healthy — 54.9% gross margin

Operating Margin

9.1%

Modest — 9.1% operating margin

ROCE

2.2%

Weak — 2.2% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-0.8%

Shrinking sales (-0.8% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

4/8 quarters

Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

3.6%

Thin free cash flow (3.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

1.71

Elevated debt (1.71)

Interest Cover

4.68x

Adequate interest coverage (4.7x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield

4.56%

Healthy income — 4.56% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend Growth

+0.0%

Dividend flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial